Biomerica Price to Sales Ratio vs Operating Income Analysis

BMRA Stock

USD 0.73 0.03 3.95%

Biomerica financial indicator trend analysis is way more than just evaluating Biomerica prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biomerica is a good investment. Please check the relationship between Biomerica Price To Sales Ratio and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

Price To Sales Ratio vs Operating Income

Price to Sales Ratio vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biomerica Price to Sales Ratio account and Operating Income. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Biomerica's Price to Sales Ratio and Operating Income is -0.12. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Operating Income in the same time period over historical financial statements of Biomerica, assuming nothing else is changed. The correlation between historical values of Biomerica's Price to Sales Ratio and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of Biomerica are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Price to Sales Ratio i.e., Biomerica's Price to Sales Ratio and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.12

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Biomerica stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Biomerica sales, a figure that is much harder to manipulate than other Biomerica multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Operating Income

Operating Income is the amount of profit realized from Biomerica operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Biomerica is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Biomerica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.The current year's Tax Provision is expected to grow to about 48 K, whereas Selling General Administrative is forecasted to decline to about 6.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	3.0M	446K	401.4K	381.3K
Total Revenue	18.9M	5.3M	6.1M	7.6M

Gross Profit Total Revenue

Biomerica fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Short Long Term Debt Total	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.66	0.74	0.99	0.89	-0.88	-0.78	0.94	0.67	0.23	0.94	0.01	0.8	0.77	0.48	0.4	0.89	0.79	0.89	1.0	0.24	-0.33	0.05	-0.11	0.61	0.85
Other Current Liab	0.66		0.74	0.62	0.42	-0.85	-0.63	0.83	0.11	-0.04	0.83	-0.62	0.53	0.39	-0.14	-0.17	0.7	0.58	0.74	0.7	-0.08	-0.17	0.56	0.37	0.22	0.61
Total Current Liabilities	0.74	0.74		0.68	0.69	-0.76	-0.8	0.75	0.47	0.3	0.75	-0.21	0.65	0.8	0.36	0.1	0.74	0.93	0.81	0.75	0.42	-0.15	0.19	-0.03	0.7	0.68
Total Stockholder Equity	0.99	0.62	0.68		0.87	-0.87	-0.75	0.94	0.66	0.18	0.94	0.03	0.78	0.72	0.46	0.44	0.87	0.74	0.86	0.99	0.19	-0.34	0.03	-0.12	0.57	0.83
Property Plant And Equipment Net	0.89	0.42	0.69	0.87		-0.64	-0.73	0.72	0.88	0.5	0.72	0.26	0.72	0.85	0.72	0.37	0.76	0.85	0.81	0.85	0.29	-0.33	-0.12	-0.25	0.72	0.71
Net Debt	-0.88	-0.85	-0.76	-0.87	-0.64		0.65	-0.97	-0.35	0.0	-0.97	0.36	-0.59	-0.55	-0.06	-0.31	-0.76	-0.71	-0.79	-0.91	-0.08	0.15	-0.38	-0.2	-0.38	-0.69
Retained Earnings	-0.78	-0.63	-0.8	-0.75	-0.73	0.65		-0.74	-0.56	-0.14	-0.74	0.12	-0.95	-0.67	-0.6	0.04	-0.95	-0.74	-0.93	-0.78	-0.16	0.52	0.23	0.44	-0.81	-0.94
Cash	0.94	0.83	0.75	0.94	0.72	-0.97	-0.74		0.43	0.05	1.0	-0.28	0.73	0.62	0.2	0.28	0.87	0.71	0.87	0.97	0.11	-0.27	0.27	0.09	0.45	0.81
Non Current Assets Total	0.67	0.11	0.47	0.66	0.88	-0.35	-0.56	0.43		0.47	0.43	0.44	0.54	0.69	0.79	0.32	0.53	0.7	0.59	0.59	0.17	-0.25	-0.33	-0.35	0.72	0.5
Non Currrent Assets Other	0.23	-0.04	0.3	0.18	0.5	0.0	-0.14	0.05	0.47		0.05	0.42	0.1	0.63	0.55	0.18	0.08	0.52	0.06	0.19	0.39	0.16	0.05	-0.02	0.39	0.06
Cash And Short Term Investments	0.94	0.83	0.75	0.94	0.72	-0.97	-0.74	1.0	0.43	0.05		-0.28	0.73	0.62	0.2	0.28	0.87	0.71	0.87	0.97	0.11	-0.27	0.27	0.09	0.45	0.81
Net Receivables	0.01	-0.62	-0.21	0.03	0.26	0.36	0.12	-0.28	0.44	0.42	-0.28		-0.04	0.34	0.57	0.46	-0.14	0.02	-0.2	-0.06	0.43	-0.08	-0.52	-0.4	0.17	-0.09
Common Stock Shares Outstanding	0.8	0.53	0.65	0.78	0.72	-0.59	-0.95	0.73	0.54	0.1	0.73	-0.04		0.63	0.64	0.0	0.97	0.6	0.91	0.79	0.16	-0.58	-0.32	-0.51	0.74	0.99
Non Current Liabilities Total	0.77	0.39	0.8	0.72	0.85	-0.55	-0.67	0.62	0.69	0.63	0.62	0.34	0.63		0.67	0.36	0.66	0.89	0.67	0.75	0.63	-0.13	-0.02	-0.19	0.72	0.62
Inventory	0.48	-0.14	0.36	0.46	0.72	-0.06	-0.6	0.2	0.79	0.55	0.2	0.57	0.64	0.67		0.23	0.52	0.53	0.47	0.42	0.39	-0.39	-0.65	-0.72	0.8	0.56
Other Current Assets	0.4	-0.17	0.1	0.44	0.37	-0.31	0.04	0.28	0.32	0.18	0.28	0.46	0.0	0.36	0.23		0.06	0.28	0.05	0.4	0.44	-0.01	-0.13	-0.13	0.14	0.05
Other Stockholder Equity	0.89	0.7	0.74	0.87	0.76	-0.76	-0.95	0.87	0.53	0.08	0.87	-0.14	0.97	0.66	0.52	0.06		0.68	0.96	0.89	0.14	-0.52	-0.12	-0.32	0.69	0.99
Total Liab	0.79	0.58	0.93	0.74	0.85	-0.71	-0.74	0.71	0.7	0.52	0.71	0.02	0.6	0.89	0.53	0.28	0.68		0.76	0.78	0.43	-0.11	0.1	-0.08	0.77	0.61
Property Plant And Equipment Gross	0.89	0.74	0.81	0.86	0.81	-0.79	-0.93	0.87	0.59	0.06	0.87	-0.2	0.91	0.67	0.47	0.05	0.96	0.76		0.89	0.13	-0.49	-0.04	-0.24	0.67	0.92
Total Current Assets	1.0	0.7	0.75	0.99	0.85	-0.91	-0.78	0.97	0.59	0.19	0.97	-0.06	0.79	0.75	0.42	0.4	0.89	0.78	0.89		0.24	-0.32	0.1	-0.07	0.58	0.85
Accounts Payable	0.24	-0.08	0.42	0.19	0.29	-0.08	-0.16	0.11	0.17	0.39	0.11	0.43	0.16	0.63	0.39	0.44	0.14	0.43	0.13	0.24		0.22	-0.04	-0.18	0.29	0.15
Short Long Term Debt Total	-0.33	-0.17	-0.15	-0.34	-0.33	0.15	0.52	-0.27	-0.25	0.16	-0.27	-0.08	-0.58	-0.13	-0.39	-0.01	-0.52	-0.11	-0.49	-0.32	0.22		0.54	0.55	-0.32	-0.55
Short Term Debt	0.05	0.56	0.19	0.03	-0.12	-0.38	0.23	0.27	-0.33	0.05	0.27	-0.52	-0.32	-0.02	-0.65	-0.13	-0.12	0.1	-0.04	0.1	-0.04	0.54		0.95	-0.45	-0.22
Intangible Assets	-0.11	0.37	-0.03	-0.12	-0.25	-0.2	0.44	0.09	-0.35	-0.02	0.09	-0.4	-0.51	-0.19	-0.72	-0.13	-0.32	-0.08	-0.24	-0.07	-0.18	0.55	0.95		-0.6	-0.42
Common Stock Total Equity	0.61	0.22	0.7	0.57	0.72	-0.38	-0.81	0.45	0.72	0.39	0.45	0.17	0.74	0.72	0.8	0.14	0.69	0.77	0.67	0.58	0.29	-0.32	-0.45	-0.6		0.7
Common Stock	0.85	0.61	0.68	0.83	0.71	-0.69	-0.94	0.81	0.5	0.06	0.81	-0.09	0.99	0.62	0.56	0.05	0.99	0.61	0.92	0.85	0.15	-0.55	-0.22	-0.42	0.7

Click cells to compare fundamentals

Biomerica Account Relationship Matchups

Biomerica fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.3M	11.8M	11.4M	14.5M	16.6M	17.5M
Other Current Liab	278.6K	540.7K	883.3K	1.2M	1.1M	1.2M
Total Current Liabilities	1.5M	1.3M	2.0M	1.9M	1.8M	1.3M
Total Stockholder Equity	14.2M	9.2M	8.3M	11.7M	13.5M	14.2M
Property Plant And Equipment Net	2.0M	1.9M	1.5M	1.2M	1.4M	1.5M
Net Debt	(6.9M)	(2.6M)	(4.5M)	(8.6M)	(7.8M)	(7.4M)
Retained Earnings	(21.9M)	(28.4M)	(35.1M)	(42.2M)	(38.0M)	(36.1M)
Cash	8.6M	4.2M	5.9M	9.7M	11.2M	11.7M
Non Current Assets Total	2.5M	2.6M	1.9M	1.7M	1.9M	1.3M
Non Currrent Assets Other	168.2K	264.2K	95.6K	79K	71.1K	67.5K
Cash And Short Term Investments	8.6M	4.2M	5.9M	9.7M	11.2M	11.7M
Net Receivables	1.8M	1.5M	773.8K	722K	649.8K	955.2K
Common Stock Shares Outstanding	10.2M	11.9M	12.7M	14.2M	16.3M	17.1M
Liabilities And Stockholders Equity	17.3M	11.8M	11.4M	14.5M	16.6M	17.5M
Non Current Liabilities Total	1.6M	1.3M	1.0M	785K	902.8K	857.6K
Inventory	2.9M	3.2M	2.4M	2.1M	2.4M	2.2M
Other Current Assets	1.5M	255.0	447.0	300K	270K	273.8K
Other Stockholder Equity	35.2M	36.7M	42.4M	52.7M	60.6M	63.6M
Total Liab	3.0M	2.6M	3.0M	2.7M	2.5M	1.4M
Property Plant And Equipment Gross	2.0M	1.9M	3.5M	3.2M	3.7M	3.9M
Total Current Assets	14.8M	9.2M	9.4M	12.8M	14.7M	15.5M
Accumulated Other Comprehensive Income	(39.8K)	(48.0K)	(73.9K)	(110K)	(126.5K)	(132.8K)
Accounts Payable	986.7K	431.6K	736K	344K	309.6K	575.0K
Intangible Assets	168.7K	294.8K	170K	165K	148.5K	276.5K
Common Stock Total Equity	711.0K	774.2K	939.2K	984.6K	1.1M	622.7K
Common Stock	939.2K	984.6K	1.0M	1.3M	1.5M	1.6M
Other Assets	168.2K	264.2K	363.0	79K	90.9K	86.3K
Property Plant Equipment	2.0M	1.9M	1.5M	1.2M	1.4M	1.5M
Net Tangible Assets	14.0M	8.9M	8.2M	11.6M	13.3M	7.8M
Net Invested Capital	14.2M	9.2M	8.3M	11.7M	13.5M	8.8M
Net Working Capital	13.3M	7.9M	7.4M	10.9M	12.5M	7.9M
Capital Stock	964.9K	984.6K	1.0M	1.3M	1.5M	1.1M

Pair Trading with Biomerica

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomerica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerica will appreciate offsetting losses from the drop in the long position's value.

Moving against Biomerica Stock

0.42	GCTK	GlucoTrack	Pair Corr
0.42	WST	West Pharmaceutical Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Biomerica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomerica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomerica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomerica to buy it.

The correlation of Biomerica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomerica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomerica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Biomerica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:

How To Invest In Biomerica

Details

Is Biomerica Stock a good investment?

Details

What is Biomerica's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Biomerica Stock analysis

When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.

	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Transaction History View history of all your transactions and understand their impact on performance
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Commodity Directory Find actively traded commodities issued by global exchanges
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.37)

Revenue Per Share

0.323

Quarterly Revenue Growth

(0.09)

Return On Assets

(0.43)

Return On Equity

(0.92)

The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biomerica Price to Sales Ratio vs Operating Income Analysis

Price To Sales Ratio vs Operating Income

Price to Sales Ratio vs Operating Income Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Operating Income

Biomerica fundamental ratios Correlations

Biomerica Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biomerica fundamental ratios Accounts

Pair Trading with Biomerica

Moving against Biomerica Stock

Complementary Tools for Biomerica Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Other Stockholder Equity

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Common Stock	- 0.94	Retained Earnings
Property Plant And Equipment Gross	- 0.93	Retained Earnings